SCHEMBL10293323

SCHEMBL10293323

Fc1ccc(-c2cnc3c(c2)CCN3)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASIC3 Q9UHC3 1/20 0.62
FEN1 P39748 4/20 0.50
ALOX5AP P20292 3/20 0.50
PIK3C3 Q8NEB9 1/20 0.50
GRM5 P41594 1/20 0.47
PIK3CD O00329 1/20 0.45
NNMT P40261 2/20 0.45
ABL1 P00519 2/20 0.45
PARP10 Q53GL7 2/20 0.41
PARP1 P09874 1/20 0.41
PARP11 Q9NR21 1/20 0.41
CYP11B2 P19099 2/20 0.39
ALK Q9UM73 2/20 0.39
PDGFRB P09619 2/20 0.39
PDGFRA P16234 2/20 0.39
CHEK1 O14757 1/20 0.39
AURKA O14965 1/20 0.39
DAPK3 O43293 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8388712 0.84 ASIC3 (0.62) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL8385558 0.83 ASIC3 (0.61) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL13533930 0.80 ASIC3 (0.58) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL13004738 0.80 ASIC3 (0.58) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL1723715 0.79 NNMT (0.53) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL10293369 0.78 NNMT (0.69) ASIC3PIK3C3PIK3CDNNMTABL1
SCHEMBL8388946 0.78 ASIC3 (0.56) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL13138515 0.78 ASIC3 (0.56) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL8385495 0.77 ASIC3 (0.57) ASIC3FEN1ALOX5APPIK3C3GRM5
SCHEMBL8385317 0.76 ASIC3 (0.57) ASIC3FEN1ALOX5APPIK3C3GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022098-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022098-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR MAP3K20, MAP3K13, MAP3K8 ASIC3 4358/4885FEN1 2321/4885ALOX5AP 4050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.